SEBI-REGISTERED PMS · EMERGING OPPORTUNITIES
Owning India’s Next Generation of Small-Cap Compounders.
We identify under-researched businesses early through deep, private equity–style research, and partner with them over the long term to compound capital with conviction.
SEBI PMS
INR
₹1 Cr min
No lock-in
Growth of ₹10 Cr · Apr '20 → Present
Equitree PMS vs Benchmarks
Live TWRR
₹79.00 Cr
Equitree PMS
Nifty SC 100
BSE 500 TRI
NET OF FEES · TWRR
Built for long-term patient capital.
5Y TWRR
22%
Net of fees, as of May 2026
Concentrated book
12 – 15
High-conviction positions
Minimum investment
₹1 Cr
Per investor
Lock-in
NIL
No exit load
STRUCTURE & REGULATION
01
The vehicle.
Strategy Name
Emerging Opportunities
Vehicle
SEBI-registered Portfolio Management Service
Manager
Equitree Capital Advisors Pvt Ltd
SEBI Registration
INP000005777
STRATEGY
02
What we buy.
Approach
Long-only, buy and hold
Focus
Indian small-cap equities
Target market cap
₹1,000 to 5,000 Cr at entry
Holding period
5+ years, low turnover
INVESTOR TERMS
03
How you participate.
Eligibility
Indian residents & Corporates (LLP, HUF, Pvt Ltd)
Onboarding
Fully digital KYC · 3 to 5 business days
Holding structure
Segregated · stocks held in investor demat
Liquidity
No lock-in · no exit load
The portfolio, in numbers.
Snapshot as of 31 May 2026
Median mkt cap
₹1,970 Cr
FY27E P/E
14.0x
FY27E EPS growth
20 – 22%
FY27E PEG
0.57
10-year P/E
16.4x
Debt-to-Equity
0.28
SECTOR ALLOCATION
| Sector | Weight (%) |
|---|---|
Infrastructure | 23.29% |
Cash | 14.32% |
Engineering Products | 12.62% |
Chemicals & Materials | 10.27% |
Apparel | 9.32% |
Auto Ancillaries | 8.42% |
Agriculture | 8.32% |
Consumer Durables | 6.89% |
Oil and Gas | 5.45% |
Others | 1.10% |
Cash includes liquid mutual fund equivalents.
Compounding through cycles.
TWRR basis, net of fees. Returns over 1Y are annualised.
PERIOD RETURNS (%)
AS OF 31 MAY 2026
RISK METRICS
| Metric | Equitree | BSE 500 |
|---|---|---|
| Sharpe Ratio | 1.39 | 1.35 |
| Sortino Ratio | 2.91 | 2.23 |
| Treynor Ratio | 31.80 | 21.40 |
| Jensen's Alpha | 12.21% | — |
| Standard Deviation | 26.86% | 15.89% |
| Semi Deviation | 5.26% | 3.19% |
| CAPM Beta | 1.17 | 1.00 |
| Tracking Risk | 5.63% | — |
RETURNS VS BENCHMARKS
AS OF 31 MAY 2026
| Series | 1M | 3M | 6M | 1Y | 2Y | 3Y | 5Y | 6Y |
|---|---|---|---|---|---|---|---|---|
| Equitree PMS | -0.69% | +8.78% | -5.71% | -6.87% | +7.97% | +27.24% | +21.76% | +36.28% |
| BSE 500 TRI | -0.17% | -2.34% | -5.39% | -0.07% | +4.14% | +13.46% | +12.29% | +19.75% |
| Nifty SC 100 | +0.73% | +7.15% | +1.74% | +1.43% | +4.23% | +21.28% | +14.38% | +27.80% |
| Outperf. vs BSE 500 | -0.52% | +11.12% | -0.32% | -6.80% | +3.83% | +13.78% | +9.47% | +16.53% |
Time, not timing, drives outcomes
Every investor who stayed invested for 3+ years has at least doubled their capital. Returns range from 25 to 50% CAGR, with a median 3-year rolling return of 25%.
Corrections compound the IRR
Cohorts that subscribed during the 2020 and 2022 drawdowns realised 37 to 38% CAGR and ~20% p.a. alpha. Lower entry prices translate directly into higher long-term returns.
A multi-cycle proprietary track record
Equitree's proprietary capital has compounded at 26% IRR since 2012 — roughly 20× over 13 years, run on the same playbook live in the PMS today.
Risk is not the same as volatility
Realised losses occurred only when investors exited during temporary price corrections. Investors that sat through volatility compounded through it.
From research to results.
Click any holding to see its full price journey. Illustrative of process, not the current portfolio.
HOLDING TIMELINE
Currently buying
2013
2015
2017
2019
2021
2023
2025
SELECTED · SPECIALTY CHEMICALS
Aarti Industries
REALISED
IRR
61.38%
MOIC
8.5x
Total return
+729%
Share price · ₹
Nov 2012 → Apr '26
Entry
Nov 2012 · ₹95
Exit
Apr 2017 · ₹788
NSE / BSE monthly closes via Yahoo Finance (split-adjusted), rescaled to the fund's realised entry/exit
Entry & exit per Equitree Capital and Nuvama Custodian Services · As of 30 Apr 2026
IMPORTANT INFORMATION
Please read carefully before acting on any content on this page.
This material is issued by Equitree Capital Advisors Private Limited ("ECAPL"), a SEBI-registered Portfolio Manager (INP000005777), for informational purposes only and does not constitute an offer or solicitation to invest. Investments will be made only on the basis of the Disclosure Document and PMS Agreement.
The Emerging Opportunities strategy is a discretionary PMS. Investments in equity, especially small and micro-cap companies, involve risks including volatility, limited liquidity, and potential loss of capital. Past performance is not indicative of future returns.
Performance, where shown, is based on Time-Weighted Rate of Return (TWRR), net of fees and expenses; returns above one year are annualised. Benchmarks are for reference only and the portfolio is not managed against any benchmark.
Investors should conduct independent due diligence and consult their legal, tax, and financial advisors before investing. ECAPL does not guarantee accuracy or completeness and assumes no obligation to update this information.
Equitree Capital Advisors Private Limited